Journal article
Rhesus theta-defensin prevents death in a mouse model of severe acute respiratory syndrome coronavirus pulmonary disease
Journal of virology, Vol.83(21), pp.11385-11390
11/2009
DOI: 10.1128/JVI.01363-09
PMCID: PMC2772759
PMID: 19710146
Abstract
We evaluated the efficacy of rhesus theta-defensin 1 (RTD-1), a novel cyclic antimicrobial peptide, as a prophylactic antiviral in a mouse model of severe acute respiratory syndrome (SARS) coronavirus (CoV) lung disease. BALB/c mice exposed to a mouse-adapted strain of SARS-CoV demonstrated 100% survival and modest reductions in lung pathology without reductions in virus titer when treated with two intranasal doses of RTD-1, while mortality in untreated mice was approximately 75%. RTD-1-treated, SARS-CoV-infected mice displayed altered lung tissue cytokine responses 2 and 4 days postinfection compared to those of untreated animals, suggesting that one possible mechanism of action for RTD-1 is immunomodulatory.
Details
- Title: Subtitle
- Rhesus theta-defensin prevents death in a mouse model of severe acute respiratory syndrome coronavirus pulmonary disease
- Creators
- Christine L Wohlford-Lenane - Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242, USADavid K MeyerholzStanley PerlmanHaixia ZhouDat TranMichael E SelstedPaul B McCray Jr
- Resource Type
- Journal article
- Publication Details
- Journal of virology, Vol.83(21), pp.11385-11390
- DOI
- 10.1128/JVI.01363-09
- PMID
- 19710146
- PMCID
- PMC2772759
- NLM abbreviation
- J Virol
- ISSN
- 0022-538X
- eISSN
- 1098-5514
- Publisher
- United States
- Grant note
- R37 AI022931 / NIAID NIH HHS R37AI022931 / NIAID NIH HHS R01 AI058129 / NIAID NIH HHS P01 AI060699 / NIAID NIH HHS R01AI058129 / NIAID NIH HHS
- Language
- English
- Date published
- 11/2009
- Academic Unit
- Microbiology and Immunology; Pulmonary Medicine; Stead Family Department of Pediatrics; Pathology; Iowa Neuroscience Institute; Infectious Disease (Pediatrics)
- Record Identifier
- 9983777348102771
Metrics
37 Record Views